Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,243,000 | 1,339,000 | 2,892,000 | 2,222,000 | 1,467,000 |
| Depreciation Amortization | 706,000 | 351,000 | 1,414,000 | 1,049,000 | 707,000 |
| Income taxes - deferred | -334,000 | -351,000 | -2,000 | 20,000 | -49,000 |
| Accounts receivable | -163,000 | -117,000 | -269,000 | -171,000 | -139,000 |
| Other Working Capital | -841,000 | -915,000 | -246,000 | -401,000 | -445,000 |
| Other Operating Activity | 211,000 | 41,000 | 745,000 | 451,000 | 286,000 |
| Operating Cash Flow | $1,822,000 | $348,000 | $4,534,000 | $3,170,000 | $1,827,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -372,000 | -177,000 | -876,000 | -525,000 | -344,000 |
| Net Acquisitions | -718,000 | -523,000 | -1,593,000 | -1,504,000 | -1,248,000 |
| Purchase Of Investment | -1,730,000 | 61,000 | -254,000 | N/A | -165,000 |
| Sale Of Investment | 229,000 | N/A | N/A | N/A | 55,000 |
| Other Investing Activity | 44,000 | 48,000 | 83,000 | -99,000 | 76,000 |
| Investing Cash Flow | $-2,547,000 | $-591,000 | $-2,640,000 | $-2,128,000 | $-1,626,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,675,000 | N/A | -196,000 | N/A | 1,000 |
| Debt Issued | 0 | 0 | 1,558,000 | 1,558,000 | 1,558,000 |
| Debt Repayment | 0 | 0 | -258,000 | -49,000 | -42,000 |
| Common Stock Issued | 86,000 | 81,000 | 282,000 | 262,000 | 147,000 |
| Common Stock Repurchased | -2,000,000 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -431,000 | -341,000 | -1,781,000 | -1,982,000 | -1,771,000 |
| Financing Cash Flow | $-670,000 | $-260,000 | $-395,000 | $-211,000 | $-107,000 |
| Exchange Rate Effect | 1,000 | 0 | 42,000 | 39,000 | 41,000 |
| Beginning Cash Position | 2,147,000 | 2,147,000 | 606,000 | 606,000 | 606,000 |
| End Cash Position | 753,000 | 1,643,000 | 2,147,000 | 1,476,000 | 741,000 |
| Net Cash Flow | $-1,394,000 | $-504,000 | $1,541,000 | $870,000 | $135,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,822,000 | 348,000 | 4,534,000 | 3,170,000 | 1,827,000 |
| Capital Expenditure | -372,000 | -177,000 | -876,000 | -525,000 | -344,000 |
| Free Cash Flow | 1,450,000 | 171,000 | 3,658,000 | 2,645,000 | 1,483,000 |